Grace Borichevsky

2024

Journal - Research Article

Swaminathan, A., Borichevsky, G. M., Frampton, C., Kettle, A. J., Peyrin-Biroulet, L., Siegel, C. A., Day, A. S., & Gearry, R. B. (2024). Development and investigation of a non-invasive disease severity index for inflammatory bowel disease. Journal of Crohn's & Colitis, jjae106. Advance online publication. doi: 10.1093/ecco-jcc/jjae106

Swaminathan, A., Borichevsky, G. M., Frampton, C. M., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2024). Comparison of fecal calprotectin and myeloperoxidase in predicting outcomes in inflammatory bowel disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izae032

2023

Journal - Research Article

Swaminathan, A., Fulforth, J. M., Frampton, C. M., Borichevsky, G. M., Mules, T. C., Kilpatrick, K., … Gearry, R. B. (2023). The Disease Severity Index for inflammatory bowel disease is a valid instrument that predicts complicated disease. Inflammatory Bowel Diseases. Advance online publication. doi: 10.1093/ibd/izad294

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G. M., Frampton, C. M., Day, A. S., & Gearry, R. B. (2023). The impact of disease activity on sexual and erectile dysfunction in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 29, 1244-1254. doi: 10.1093/ibd/izac204

Journal - Research Other

Swaminathan, A., Frampton, C. M., Borichevsky, G. M., Kettle, A. J., & Gearry, R. B. (2023). Response to "Evaluating discriminative accuracy of biomarkers in relation to binary study outcomes: First validate, then celebrate?" Journal of Crohn's & Colitis, 17, 147-148. doi: 10.1093/ecco-jcc/jjac126

2022

Journal - Research Article

Swaminathan, A., Borichevsky, G. M., Edwards, T. S., Hirschfeld, E., Mules, T. C., Frampton, C. M. A., Day, A. S., Hampton, M. B., Kettle, A. J., & Gearry, R. B. (2022). Faecal myeloperoxidase as a biomarker of endoscopic activity in inflammatory bowel disease. Journal of Crohn's & Colitis, 16, 1862-1873. doi: 10.1093/ecco-jcc/jjac098

Swaminathan, A., Fan, D., Borichevsky, G. M., Mules, T. C., Hirschfeld, E., Frampton, C. M., Day, A. S., … Gearry, R. B. (2022). The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. Alimentary Pharmacology & Therapeutics, 56, 664-674. doi: 10.1111/apt.17058

Mules, T. C., Swaminathan, A., Hirschfeld, E., Borichevsky, G., Frampton, C., Day, A. S., & Gearry, R. B. (2022). The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Alimentary Pharmacology & Therapeutics, 55, 201-211. doi: 10.1111/apt.16616

2021

Conference Contribution - Published proceedings: Abstract

Borichevsky, G., Swaminathan, A., Edwards, T., Day, A., Hampton, M., Kettle, A., & Gearry, R. (2021). Faecal myeloperoxidase is a biomarker of endoscopically active inflammatory bowel disease. Proceedings of the 16th Congress of the Federation of Asian & Oceanic Biochemists & Molecular Biologists (FAOBMB). (pp. 234). Retrieved from https://www.faobmb2021.org